Disclosing Adverse Events to Patients

The rationale for, and recommended approaches to, disclosing adverse events to patients are examined on the basis of the experience of the Veterans Health Administration (VHA). The VHA’s National Ethics Committee endorses a general policy requiring the routine disclosure of adverse events to patient...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Joint Commission journal on quality and patient safety 2005-01, Vol.31 (1), p.5-12
Hauptverfasser: Cantor, Michael D., Barach, Paul, Derse, Arthur, Maklan, Claire W., Wlody, Ginger Schafer, Fox, Ellen
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 12
container_issue 1
container_start_page 5
container_title Joint Commission journal on quality and patient safety
container_volume 31
creator Cantor, Michael D.
Barach, Paul
Derse, Arthur
Maklan, Claire W.
Wlody, Ginger Schafer
Fox, Ellen
description The rationale for, and recommended approaches to, disclosing adverse events to patients are examined on the basis of the experience of the Veterans Health Administration (VHA). The VHA’s National Ethics Committee endorses a general policy requiring the routine disclosure of adverse events to patients and offers practical recommendations for implementation. Disclosure is required when the adverse event (1) has a perceptible effect on the patient that was not discussed in advance as a known risk; (2) necessitates a change in the patient’s care; (3) potentially poses an important risk to the patient’s future health, even if that risk is extremely small; (4) involves providing a treatment or procedure without the patient’s consent. From an ethical perspective, disclosure is required and should not be limited to cases in which the injury is obvious or severe. Disclosure of near misses is also discretionary but is advisable at times. In general, disclosure by a clinician involved in the patient’s care is appropriate. Although a variety of psychological and cultural factors may make clinicians and organizations reluctant to disclose adverse events to patients, the arguments favoring routine disclosure are compelling. Organizations should develop clear policies supporting disclosure and should create supportive environments that enable clinicians to meet their ethical obligations to disclose adverse events to patients and families.
doi_str_mv 10.1016/S1553-7250(05)31002-6
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67401230</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1553725005310026</els_id><sourcerecordid>67401230</sourcerecordid><originalsourceid>FETCH-LOGICAL-c278t-4b85d61c64a3c55eaa9ba8ffeb7c33e71f6a0b4f870c7e2295509857fefab72f3</originalsourceid><addsrcrecordid>eNqFkMtKAzEUhoMotlYfQZmNoovRk2SSzKxKqfUCBQUV3IVM5kRGpp2aTAu-velFXLo6Z_H95_IRckrhmgKVNy9UCJ4qJuASxBWnACyVe6RPC56nlNP3_dj_Ij1yFMInAJeyyA9JjwpZUAaiT85v62CbNtTzj2RUrdAHTCYrnHch6drk2XT1uj8mB840AU92dUDe7iav44d0-nT_OB5NU8tU3qVZmYtKUiszw60QaExRmtw5LJXlHBV10kCZuVyBVchYIQQUuVAOnSkVc3xALrZzF779WmLo9Cyeh01j5tgug5YqA8o4RFBsQevbEDw6vfD1zPhvTUGv_eiNH71-XoPQGz9axtzZbsGynGH1l9oJicBwC2B8c1Wj18FGBRar2qPtdNXW_6z4AVMDc_k</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67401230</pqid></control><display><type>article</type><title>Disclosing Adverse Events to Patients</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Cantor, Michael D. ; Barach, Paul ; Derse, Arthur ; Maklan, Claire W. ; Wlody, Ginger Schafer ; Fox, Ellen</creator><creatorcontrib>Cantor, Michael D. ; Barach, Paul ; Derse, Arthur ; Maklan, Claire W. ; Wlody, Ginger Schafer ; Fox, Ellen</creatorcontrib><description>The rationale for, and recommended approaches to, disclosing adverse events to patients are examined on the basis of the experience of the Veterans Health Administration (VHA). The VHA’s National Ethics Committee endorses a general policy requiring the routine disclosure of adverse events to patients and offers practical recommendations for implementation. Disclosure is required when the adverse event (1) has a perceptible effect on the patient that was not discussed in advance as a known risk; (2) necessitates a change in the patient’s care; (3) potentially poses an important risk to the patient’s future health, even if that risk is extremely small; (4) involves providing a treatment or procedure without the patient’s consent. From an ethical perspective, disclosure is required and should not be limited to cases in which the injury is obvious or severe. Disclosure of near misses is also discretionary but is advisable at times. In general, disclosure by a clinician involved in the patient’s care is appropriate. Although a variety of psychological and cultural factors may make clinicians and organizations reluctant to disclose adverse events to patients, the arguments favoring routine disclosure are compelling. Organizations should develop clear policies supporting disclosure and should create supportive environments that enable clinicians to meet their ethical obligations to disclose adverse events to patients and families.</description><identifier>ISSN: 1553-7250</identifier><identifier>EISSN: 1938-131X</identifier><identifier>DOI: 10.1016/S1553-7250(05)31002-6</identifier><identifier>PMID: 15691205</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><subject>Bioethics ; Family ; Humans ; Patients - psychology ; Physician-Patient Relations ; Truth Disclosure - ethics</subject><ispartof>Joint Commission journal on quality and patient safety, 2005-01, Vol.31 (1), p.5-12</ispartof><rights>2005 Joint Commission on Accreditation of Healthcare Organizations</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c278t-4b85d61c64a3c55eaa9ba8ffeb7c33e71f6a0b4f870c7e2295509857fefab72f3</citedby><cites>FETCH-LOGICAL-c278t-4b85d61c64a3c55eaa9ba8ffeb7c33e71f6a0b4f870c7e2295509857fefab72f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15691205$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cantor, Michael D.</creatorcontrib><creatorcontrib>Barach, Paul</creatorcontrib><creatorcontrib>Derse, Arthur</creatorcontrib><creatorcontrib>Maklan, Claire W.</creatorcontrib><creatorcontrib>Wlody, Ginger Schafer</creatorcontrib><creatorcontrib>Fox, Ellen</creatorcontrib><title>Disclosing Adverse Events to Patients</title><title>Joint Commission journal on quality and patient safety</title><addtitle>Jt Comm J Qual Patient Saf</addtitle><description>The rationale for, and recommended approaches to, disclosing adverse events to patients are examined on the basis of the experience of the Veterans Health Administration (VHA). The VHA’s National Ethics Committee endorses a general policy requiring the routine disclosure of adverse events to patients and offers practical recommendations for implementation. Disclosure is required when the adverse event (1) has a perceptible effect on the patient that was not discussed in advance as a known risk; (2) necessitates a change in the patient’s care; (3) potentially poses an important risk to the patient’s future health, even if that risk is extremely small; (4) involves providing a treatment or procedure without the patient’s consent. From an ethical perspective, disclosure is required and should not be limited to cases in which the injury is obvious or severe. Disclosure of near misses is also discretionary but is advisable at times. In general, disclosure by a clinician involved in the patient’s care is appropriate. Although a variety of psychological and cultural factors may make clinicians and organizations reluctant to disclose adverse events to patients, the arguments favoring routine disclosure are compelling. Organizations should develop clear policies supporting disclosure and should create supportive environments that enable clinicians to meet their ethical obligations to disclose adverse events to patients and families.</description><subject>Bioethics</subject><subject>Family</subject><subject>Humans</subject><subject>Patients - psychology</subject><subject>Physician-Patient Relations</subject><subject>Truth Disclosure - ethics</subject><issn>1553-7250</issn><issn>1938-131X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMtKAzEUhoMotlYfQZmNoovRk2SSzKxKqfUCBQUV3IVM5kRGpp2aTAu-velFXLo6Z_H95_IRckrhmgKVNy9UCJ4qJuASxBWnACyVe6RPC56nlNP3_dj_Ij1yFMInAJeyyA9JjwpZUAaiT85v62CbNtTzj2RUrdAHTCYrnHch6drk2XT1uj8mB840AU92dUDe7iav44d0-nT_OB5NU8tU3qVZmYtKUiszw60QaExRmtw5LJXlHBV10kCZuVyBVchYIQQUuVAOnSkVc3xALrZzF779WmLo9Cyeh01j5tgug5YqA8o4RFBsQevbEDw6vfD1zPhvTUGv_eiNH71-XoPQGz9axtzZbsGynGH1l9oJicBwC2B8c1Wj18FGBRar2qPtdNXW_6z4AVMDc_k</recordid><startdate>200501</startdate><enddate>200501</enddate><creator>Cantor, Michael D.</creator><creator>Barach, Paul</creator><creator>Derse, Arthur</creator><creator>Maklan, Claire W.</creator><creator>Wlody, Ginger Schafer</creator><creator>Fox, Ellen</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200501</creationdate><title>Disclosing Adverse Events to Patients</title><author>Cantor, Michael D. ; Barach, Paul ; Derse, Arthur ; Maklan, Claire W. ; Wlody, Ginger Schafer ; Fox, Ellen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c278t-4b85d61c64a3c55eaa9ba8ffeb7c33e71f6a0b4f870c7e2295509857fefab72f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Bioethics</topic><topic>Family</topic><topic>Humans</topic><topic>Patients - psychology</topic><topic>Physician-Patient Relations</topic><topic>Truth Disclosure - ethics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cantor, Michael D.</creatorcontrib><creatorcontrib>Barach, Paul</creatorcontrib><creatorcontrib>Derse, Arthur</creatorcontrib><creatorcontrib>Maklan, Claire W.</creatorcontrib><creatorcontrib>Wlody, Ginger Schafer</creatorcontrib><creatorcontrib>Fox, Ellen</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Joint Commission journal on quality and patient safety</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cantor, Michael D.</au><au>Barach, Paul</au><au>Derse, Arthur</au><au>Maklan, Claire W.</au><au>Wlody, Ginger Schafer</au><au>Fox, Ellen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Disclosing Adverse Events to Patients</atitle><jtitle>Joint Commission journal on quality and patient safety</jtitle><addtitle>Jt Comm J Qual Patient Saf</addtitle><date>2005-01</date><risdate>2005</risdate><volume>31</volume><issue>1</issue><spage>5</spage><epage>12</epage><pages>5-12</pages><issn>1553-7250</issn><eissn>1938-131X</eissn><abstract>The rationale for, and recommended approaches to, disclosing adverse events to patients are examined on the basis of the experience of the Veterans Health Administration (VHA). The VHA’s National Ethics Committee endorses a general policy requiring the routine disclosure of adverse events to patients and offers practical recommendations for implementation. Disclosure is required when the adverse event (1) has a perceptible effect on the patient that was not discussed in advance as a known risk; (2) necessitates a change in the patient’s care; (3) potentially poses an important risk to the patient’s future health, even if that risk is extremely small; (4) involves providing a treatment or procedure without the patient’s consent. From an ethical perspective, disclosure is required and should not be limited to cases in which the injury is obvious or severe. Disclosure of near misses is also discretionary but is advisable at times. In general, disclosure by a clinician involved in the patient’s care is appropriate. Although a variety of psychological and cultural factors may make clinicians and organizations reluctant to disclose adverse events to patients, the arguments favoring routine disclosure are compelling. Organizations should develop clear policies supporting disclosure and should create supportive environments that enable clinicians to meet their ethical obligations to disclose adverse events to patients and families.</abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>15691205</pmid><doi>10.1016/S1553-7250(05)31002-6</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1553-7250
ispartof Joint Commission journal on quality and patient safety, 2005-01, Vol.31 (1), p.5-12
issn 1553-7250
1938-131X
language eng
recordid cdi_proquest_miscellaneous_67401230
source MEDLINE; Alma/SFX Local Collection
subjects Bioethics
Family
Humans
Patients - psychology
Physician-Patient Relations
Truth Disclosure - ethics
title Disclosing Adverse Events to Patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T10%3A26%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Disclosing%20Adverse%20Events%20to%20Patients&rft.jtitle=Joint%20Commission%20journal%20on%20quality%20and%20patient%20safety&rft.au=Cantor,%20Michael%20D.&rft.date=2005-01&rft.volume=31&rft.issue=1&rft.spage=5&rft.epage=12&rft.pages=5-12&rft.issn=1553-7250&rft.eissn=1938-131X&rft_id=info:doi/10.1016/S1553-7250(05)31002-6&rft_dat=%3Cproquest_cross%3E67401230%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67401230&rft_id=info:pmid/15691205&rft_els_id=S1553725005310026&rfr_iscdi=true